Learn More
Medchemexpress LLC Luvixasertib hydrochloride | 1610677-37-6 | 99.6% | 535.04 g/mol | C28H31ClN6O3 | 100 MG

Supplier: Medchemexpress LLC HY101340A100MG
Luvixasertib hydrochloride is a selective, orally bioavailable inhibitor of the TTK/Mps1 kinase with potent in vitro activity (IC50 = 1.7 nM) and demonstrated antitumor efficacy in preclinical models. Supplied as a light-yellow solid hydrochloride salt for research use, the compound is characterized by high purity and defined storage recommendations.
- Selective TTK/Mps1 kinase inhibition
- Potent in vitro activity with IC50 of 1.7 nM
- Demonstrated antitumor activity in xenograft and patient-derived models
- High reported purity (99.63%)
- Supplied as a light-yellow solid suitable for formulation or dissolution
- Available in multiple pack sizes, including 100 mg
- Storage: solid at 4°C; in solution -80°C for long-term stability
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.